Discovery of a Potent and Mutant-Selective EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Lung Cancer

被引：0
|
作者：
Dong Ha Kim
Yun Jung Choi
Seon Ye Kim
Jung-Eun Lee
Ki Jung Sung
Young Hoon Sung
Woo Sung Kim
Sung-Eun Kim
Hyung Chul Ryu
Jae Sun Kim
Lu Guangying
Chang-Min Choi
Jin Kyung Rho
Jae Cheol Lee
机构：
[1] University of Ulsan,Department of Pulmonology and Critical Care Medicine, Asan Medical Center
[2] College of Medicine,Asan Institute for Life Sciences, Asan Medical Center
[3] University of Ulsan,Department of Convergence Medicine, Asan Medical Center
[4] College of Medicine,East China University of Science and Technology
[5] University of Ulsan,Department of Oncology, Asan Medical Center
[6] College of Medicine,Department of Asan Institute for Life Sciences, College of Medicine
[7] Oncobix,Department of Oncology, Asan Medical Center
[8] J2H Biotech,undefined
[9] College of Pharmacy,undefined
[10] University of Ulsan,undefined
[11] College of Medicine,undefined
[12] University of Ulsan,undefined
[13] University of Ulsan College of Medicine,undefined
来源：
Targeted Oncology | 2018年 / 13卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：389 / 398
页数：9
相关论文
共 50 条
  • [1] Discovery of a Potent and Mutant-Selective EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Lung Cancer
    Kim, Dong Ha
    Choi, Yun Jung
    Kim, Seon Ye
    Lee, Jung-Eun
    Sung, Ki Jung
    Sung, Young Hoon
    Kim, Woo Sung
    Kim, Sung-Eun
    Ryu, Hyung Chul
    Kim, Jae Sun
    Lu Guangying
    Choi, Chang-Min
    Rho, Jin Kyung
    Lee, Jae Cheol
    [J]. TARGETED ONCOLOGY, 2018, 13 (03) : 389 - 398
  • [2] Discovery of a Mutant-Selective Covalent Inhibitor of EGFR that Overcomes T790M-Mediated Resistance in NSCLC
    Walter, Annette O.
    Sjin, Robert Tjin Tham
    Haringsma, Henry J.
    Ohashi, Kadoaki
    Sun, Jing
    Lee, Kwangho
    Dubrovskiy, Aleksandr
    Labenski, Matthew
    Zhu, Zhendong
    Wang, Zhigang
    Sheets, Michael
    St Martin, Thia
    Karp, Russell
    van Kalken, Dan
    Chaturvedi, Prasoon
    Niu, Deqiang
    Nacht, Mariana
    Petter, Russell C.
    Westlin, William
    Lin, Kevin
    Jaw-Tsai, Sarah
    Raponi, Mitch
    Van Dyke, Terry
    Etter, Jeff
    Weaver, Zoe
    Pao, William
    Singh, Juswinder
    Simmons, Andrew D.
    Harding, Thomas C.
    Allen, Andrew
    [J]. CANCER DISCOVERY, 2013, 3 (12) : 1404 - 1415
  • [3] Preclinical assessment of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC.
    Simmons, Andrew D.
    Haringsma, Henry J.
    Walter, Annette O.
    Sjin, Robert Tjin Tham
    Weaver, Zoe
    Allen, Andrew
    Harding, Thomas C.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [4] Novel Selective and Potent EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer
    Li, Yanxia
    Song, Zhendong
    Jin, Yue
    Tang, Zeyao
    Kang, Jian
    Ma, Xiaodong
    [J]. MOLECULES, 2016, 21 (11)
  • [5] CK-101 (RX518), a mutant-selective inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC
    Qian, Xiangping
    Zhu, Yong-Liang
    Cullen, Edward
    Niecestro, Robert M.
    Oliviero, James F.
    [J]. CANCER RESEARCH, 2017, 77
  • [6] EGF816, a novel covalent inhibitor of mutant-selective epidermal growth factor receptor, overcomes T790M-mediated resistance in NSCLC
    Kasibhatla, Shailaja
    Li, Jie
    Tompkins, Celin
    Vaillancourt, Mei-Ting
    Anderson, Jennifer
    Pferdekamper, AnneMarie Culazzo
    Li, Chun
    Long, Oliver
    McNeill, Mathew
    Epple, Robert
    Liao, Debbie
    Murphy, Eric
    Bender, Steve
    Jia, Yong
    Lelais, Gerald
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [7] AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer
    Cross, Darren A. E.
    Ashton, Susan E.
    Ghiorghiu, Serban
    Eberlein, Cath
    Nebhan, Caroline A.
    Spitzler, Paula J.
    Orme, Jonathon P.
    Finlay, M. Raymond V.
    Ward, Richard A.
    Mellor, Martine J.
    Hughes, Gareth
    Rahi, Amar
    Jacobs, Vivien N.
    Brewer, Monica Red
    Ichihara, Eiki
    Sun, Jing
    Jin, Hailing
    Ballard, Peter
    Al-Kadhimi, Katherine
    Rowlinson, Rachel
    Klinowska, Teresa
    Richmond, Graham H. P.
    Cantarini, Mireille
    Kim, Dong-Wan
    Ranson, Malcolm R.
    Pao, William
    [J]. CANCER DISCOVERY, 2014, 4 (09) : 1046 - 1061
  • [8] A novel treatment strategy for EGFR mutant NSCLC with T790M-mediated acquired resistance
    Taube, Erika
    Jokinen, Elina
    Koivunen, Peppi
    Koivunen, Jussi P.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (04) : 970 - 979
  • [9] CO-1686, a novel mutant selective EGFR inhibitor, overcomes T790M mediated resistance in Non-Small Cell Lung Cancer (NSCLC)
    Walter, Annette O.
    Tjin, Robert
    Haringsma, Henry
    Lin, Kevin
    Dubrovskiy, Alex
    Lee, Kwangho
    St Martin, Thia
    Karp, Russell
    Zhu, Zhendong
    Nu, Deqiang
    Nacht, Mariana
    Suda, Kenichi
    Mitsudomi, Tetsuya
    Petter, Russell C.
    Westlin, William F.
    Singh, Juswinder
    Raponi, Mitch
    Allen, Andrew
    [J]. CANCER RESEARCH, 2012, 72
  • [10] Novel T790M mutant-selective EGFR kinase inhibitors
    不详
    [J]. PHARMACOGENOMICS, 2010, 11 (06) : 744 - 744
12345